Identification of novel covalent ligands that disrupt Acetyl-Lysine binding to the SETDB1 tudor domain

Jun Ma1, Yunyuan Huang1, Tao Zheng2

  • 1Key Laboratory of Pesticide and Chemical Biology of Ministry of Education, Hubei Key Laboratory of Genetic Regulation and Integrative Biology, School of Life Sciences, Central China Normal University, Wuhan, 430079, China.

Insights

Researchers identified new covalent ligands, XY047 and XY087, targeting the SETDB1 Tudor domain's Kac pocket. These compounds are valuable tools for studying SETDB1's role in diseases like cancer and neurodegeneration.

Area of Science:

  • Biochemistry
  • Epigenetics
  • Chemical Biology

Background:

  • SETDB1 is a histone methylation reader implicated in cancer and neurodegenerative diseases.
  • Its Tudor domain recognizes H3K9me2/K14ac marks through Kme and Kac pockets.
  • Targeting the SETDB1 Kac pocket presents a therapeutic opportunity, but ligands are underexplored.

Purpose of the Study:

  • To identify novel covalent ligands targeting the SETDB1 Tudor domain's Kac pocket.
  • To develop chemical tools for investigating SETDB1's biological functions in disease.

Main Methods:

  • Differential scanning fluorimetry (DSF) screening.
  • Iodoacetamide-rhodamine (IA-rhodamine, IAR) assay.
  • Cell lysate-based binding assays.

Main Results:

  • Two covalent ligands, XY047 and XY087, were identified.
  • These ligands primarily target Cys329 and bind to the SETDB1 Tudor domain's Kac pocket.
  • Binding activity was confirmed in cell lysates.

Conclusions:

  • XY047 and XY087 are effective covalent inhibitors of the SETDB1 Tudor domain.
  • These ligands serve as valuable chemical probes for SETDB1 research.
  • The findings advance the development of SETDB1-targeted therapeutics for cancer and neurodegeneration.

Related Concept Videos

Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.4K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
8.2K
Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.1K